FTO can downregulate the expression of ASB2 and RARA by reducing m6A levels in UTRs of transcripts, resulting in the inhibition of ATRA-mediated acute myeloid leukemia (AML) cell differentiation [84]. This evidence concerns the gene ASB2 and acute myeloid leukemia.